INS and type 2 diabetes mellitus: In adults with type 2 diabetes under multiple daily insulin injections (MDI), isCGM has been observed to improve glycated haemoglobin (HbA1c) [4], with reductions in hypoglycaemia [5,6] and increased treatment satisfaction [4,5].